IR
IRIDEX Corporation
IRIX · NASDAQ
$0.67 +5.51% (+$0.04)
1M -10.24%
Market Cap $11.3M
P/E Ratio -
Div. Yield -
ROE 78.94%
Bulios Fair Price
$0.91
35.8% upside
Current Price
$0.67
Undervalued Fair Value Overvalued
According to Bulios Fair Price, IRIX is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
3/9Valuation
83 /100
Cheap P/B 3.10x
P/S 0.22x
EV/FFO N/A
Growth
5 /100
Declining Book val. growth 34.14%
Rev. growth 2.58%
FCF growth N/A
Profitability
14 /100
Weak Net margin 6.88%
Op. margin 5.39%
FCF margin 3.43%
Quality
15 /100
Poor ROE 78.94%
ROA 13.01%
Asset turnover 1.89x
Debt
97 /100
Low Current ratio 1.82x
Debt/Equity 0.06x
Net debt/EBITDA N/A
Stability
70 /100
Stable Rev. volatility 9.22%
EPS volatility 38.79%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about IRIX
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Patrick Mercer
Employees
93
Headquarters
Mountain View
Upcoming events
17 NOV
Earnings
Upcoming earnings report